Answers are grounded in this paper and cite their sources.
These findings confirm that major INSTI-RMs very rarely occur in INSTI-naïve patients. Under INSTI treatment, selection of drug-resistance follows the typical drug-resistance pathways; a higher evolution characterises integrase sequences developing drug-resistance compared with those without any resistance.
No takes yet. Share an insight, caveat, or question.
Scutari et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: